Genentech gets approval for Cathflo Activase

Pharmaceutical firm Genentech has received Food and Drug Administration approval for its thrombolytic agent Cathflo Activase. The product is a tissue plasminogen activator (t-PA) indicated for the restoration of function to central venous access devices (CVADs), as assessed by the ability to withdraw blood, according to the South San Francisco, CA-based vendor.

By AuntMinnie.com staff writers
September 6, 2001

Related Reading

t-PA highly effective in unclogging catheters, January 23, 2001

Copyright © 2001 AuntMinnie.com

Page 1 of 376
Next Page